Research On Financial Diagnosis And Management Optimization Of ZS Company

Financial analysis is an analytical method that accurately reflects the problems of business management and business performance,and explores the problems in the management of enterprises.Financial analysis is an analysis tool for enterprises to carry out financial diagnosis.They are effective for financial management optimization and are effective for managers.Fundamental conditions for financial management.At present,China as the world’s third largest pharmaceutical market,the pharmaceutical industry has become an important part of the modern economy,as the rapid development of pharmaceutical industry in Guangdong Province,ZS companies face R & D investment and performance matching rate is low,the expansion of expansion policy Under the influence of weak solvency,cost control and other issues weak.Therefore,this paper takes ZS as an example to analyze the advantages and disadvantages of its operation and put forward the suggestions of financial management optimization.This part is composed of seven parts: The first part is the introduction,which mainly introduces the research background and significance,the research status quo at home and abroad,the research content,the method and the thought;The second part is the related concept and the basic theory outline;The third part is the basic situation of ZS company;The fourth part is the diagnosis of ZS company,first through the PEST,Porter five force model,SWOT analysis from the macro environment,industry status,the company’s own advantages and disadvantages of the three aspects of corporate financial strategy diagnosis,followed by the company’s major accounting policies and The current situation is based on the solvency of the solvency,the profitability,the operational capacity and the cash flow situation,and finds out the shortcomings in the management and management.Finally,the foreground analysis is used to forecast the development trend of the company.The fifth part Is the comprehensive evaluation of the company’s financial diagnosis and the causes of the existence of the problem analysis;the sixth part of the financial management optimization recommendations;the seventh part is the conclusion and outlook.Based on the annual report of ZS 2011-2015,this paper uses the Harvard analysis framework to find out the problem of financial diagnosis,and uses Du Pont analysis method and chain replacement method to find out the reason.The diagnosis shows that the overall development of the company shows a positive situation and makes a reasonable Financial development strategy and management system,but the individual indicators in recent years,mergers and acquisitions,market economy slowed down the reasons for the emergence of fluctuations or bad development;inventory and accounts receivable turnover rate is low;product development strategy execution is unsatisfactory,R & D investment rate does not greatly improve the company’s market share;cost control is weak;the company’s merger makes short-term solvency weakened,the risk of debt increase.This requires the company from the development of financial strategy to optimize the design,improve the financial accounting management and disclosure,enhance the company’s financial performance and operational efficiency,good research and development and internal and external resources under the financial outlook forecast four aspects,given specific views.Through summarizing the summary,this article draws inspiration,finds out the direction of its development,and gives reference to the other business ideas of the pharmaceutical enterprises.